share_log

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Maintains $14.25 Price Target

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Maintains $14.25 Price Target

坎托·菲茨杰拉德维持对Cresco Labs的增持,维持14.25美元的目标股价
Benzinga ·  2023/02/24 06:53

Cantor Fitzgerald analyst Pablo Zuanic maintains Cresco Labs (OTC:CRLBF) with a Overweight and maintains $14.25 price target.

坎托·菲茨杰拉德分析师巴勃罗·祖尼奇维持Cresco Labs(场外交易代码:CRLBF)的增持,并维持14.25美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发